Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.
about
Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activitiesEffect of mutations to amino acid A301 and F361 in thermostability and catalytic activity of the β-galactosidase from Bacillus subtilis VTCC-DVN-12-01.Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapy.
P2860
Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@en
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@nl
type
label
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@en
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@nl
prefLabel
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@en
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@nl
P2093
P2860
P1476
Generation and characterizatio ...... studies in GM1 gangliosidosis.
@en
P2093
Alexandre M Samoylov
Anna M Cochran
Douglas R Martin
Henry J Baker
Misako Hwang
Nancy E Morrison
Nancy R Cox
Tatiana I Samoylova
P2860
P2888
P304
P356
10.1007/S11011-008-9086-5
P577
2008-04-18T00:00:00Z